Literature DB >> 19628742

Inhibition of RhoA signaling with increased Bves in trabecular meshwork cells.

Patricia K Russ1, Asher I Kupperman, Sai-Han Presley, Frederick R Haselton, Min S Chang.   

Abstract

PURPOSE: Blood vessel epicardial substance (Bves) is a novel adhesion molecule that regulates tight junction (TJ) formation. TJs also modulate RhoA signaling, which has been implicated in outflow regulation. Given that Bves has been reported in multiple ocular tissues, the authors hypothesize that Bves plays a role in the regulation of RhoA signaling in trabecular meshwork (TM) cells.
METHODS: Human TM cell lines NTM-5 and NTM-5 transfected to overexpress Bves (NTM-w) were evaluated for TJ formation, and levels of occludin, cingulin, and ZO-1 protein were compared. Assays of TJ function were carried out using diffusion of sodium fluorescein and transcellular electrical resistance (TER). Levels of activated RhoA were measured using FRET probes, and phosphorylation of myosin light chain (MLC-p), a downstream target of RhoA, was assessed by Western blot analysis.
RESULTS: Overexpression of Bves led to increased TJ formation in NTM-5 cells. Increased TJ formation was confirmed by increased occludin, cingulin, and ZO-1 protein. Functionally, NTM-w cells showed decreased permeability and increased TER compared with NTM-5 cells, consistent with increased TJ formation. NTM-w cells also exhibited decreased levels of active RhoA and lower levels of MLC-p than did NTM-5 cells. These findings support a TJ role in RhoA signaling.
CONCLUSIONS: Increased Bves in TM cells leads to increased TJ formation with decreased RhoA activation and decreased MLC-p. This is the first report of a regulatory pathway upstream of RhoA in TM cells. In TM tissue, RhoA has been implicated in outflow regulation; thus, Bves may be a key regulatory molecule in aqueous outflow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628742      PMCID: PMC2857412          DOI: 10.1167/iovs.09-3539

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  37 in total

1.  Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork.

Authors:  Rita Rosenthal; Lars Choritz; Sebastian Schlott; Nikolaos E Bechrakis; Jan Jaroszewski; Michael Wiederholt; Hagen Thieme
Journal:  Exp Eye Res       Date:  2005-06       Impact factor: 3.467

2.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

Review 3.  Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes.

Authors:  Myriam Polette; Mélanie Mestdagt; Sandrine Bindels; Béatrice Nawrocki-Raby; Walter Hunziker; Jean-Michel Foidart; Philippe Birembaut; Christine Gilles
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

4.  Bves modulates epithelial integrity through an interaction at the tight junction.

Authors:  Megan E Osler; Min S Chang; David M Bader
Journal:  J Cell Sci       Date:  2005-09-27       Impact factor: 5.285

5.  FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35.

Authors:  Janet Chusainow; Paul M Ajuh; Laura Trinkle-Mulcahy; Judith E Sleeman; Jan Ellenberg; Angus I Lamond
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

6.  Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition.

Authors:  Saima Aijaz; Fabio D'Atri; Sandra Citi; Maria S Balda; Karl Matter
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

7.  Effects of endothelin-1 on human trabecular meshwork cell contraction. an in vitro cell culture model.

Authors:  Mauro Cellini; Piera Versura; Davide Trerè; Emilio C Campos
Journal:  Ophthalmic Res       Date:  2004-12-30       Impact factor: 2.892

8.  Xbves is a regulator of epithelial movement during early Xenopus laevis development.

Authors:  Anna N Ripley; Megan E Osler; Christopher V E Wright; David Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

Review 9.  Epithelial tight junctions, gene expression and nucleo-junctional interplay.

Authors:  Karl Matter; Maria Susana Balda
Journal:  J Cell Sci       Date:  2007-05-01       Impact factor: 5.285

Review 10.  Tight junctions: molecular architecture and function.

Authors:  Saima Aijaz; Maria S Balda; Karl Matter
Journal:  Int Rev Cytol       Date:  2006
View more
  17 in total

1.  Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family.

Authors:  Emily Steed; Nelio T L Rodrigues; Maria S Balda; Karl Matter
Journal:  BMC Cell Biol       Date:  2009-12-22       Impact factor: 4.241

2.  Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Authors:  Deng Luo; Hua Huang; Ming-Liang Lu; Gong-Fang Zhao; Jiang Chang; Meng-Yao Zheng; Yan Wang
Journal:  Pathol Oncol Res       Date:  2011-11-23       Impact factor: 3.201

3.  Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma.

Authors:  Ping Han; Yu Fu; Jingmei Liu; Yunwu Wang; Jiayi He; Jin Gong; Mengke Li; Qinghai Tan; Dongxiao Li; Yixing Luo; Jian Han; Jiqiao Liu; Wei Tu; Ying Wang; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma.

Authors:  Ashwath Jayagopal; Jin-Long Yang; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

Review 5.  RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Haibing Chen; Xun Xu; Zhi Zheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

Review 6.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

7.  Bves modulates tight junction associated signaling.

Authors:  Patricia K Russ; Christopher J Pino; Christopher S Williams; David M Bader; Frederick R Haselton; Min S Chang
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance.

Authors:  Yifat Alcalay; Edith Hochhauser; Vitaly Kliminski; Julia Dick; Muayad A Zahalka; Doris Parnes; Hadassa Schlesinger; Zaid Abassi; Asher Shainberg; Roland F R Schindler; Thomas Brand; Gania Kessler-Icekson
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

9.  Bves and NDRG4 regulate directional epicardial cell migration through autocrine extracellular matrix deposition.

Authors:  Emily C Benesh; Paul M Miller; Elise R Pfaltzgraff; Nathan E Grega-Larson; Hillary A Hager; Bong Hwan Sung; Xianghu Qu; H Scott Baldwin; Alissa M Weaver; David M Bader
Journal:  Mol Biol Cell       Date:  2013-09-18       Impact factor: 4.138

10.  Common genetic determinants of intraocular pressure and primary open-angle glaucoma.

Authors:  Leonieke M E van Koolwijk; Wishal D Ramdas; M Kamran Ikram; Nomdo M Jansonius; Francesca Pasutto; Pirro G Hysi; Stuart Macgregor; Sarah F Janssen; Alex W Hewitt; Ananth C Viswanathan; Jacoline B ten Brink; S Mohsen Hosseini; Najaf Amin; Dominiek D G Despriet; Jacqueline J M Willemse-Assink; Rogier Kramer; Fernando Rivadeneira; Maksim Struchalin; Yurii S Aulchenko; Nicole Weisschuh; Matthias Zenkel; Christian Y Mardin; Eugen Gramer; Ulrich Welge-Lüssen; Grant W Montgomery; Francis Carbonaro; Terri L Young; Céline Bellenguez; Peter McGuffin; Paul J Foster; Fotis Topouzis; Paul Mitchell; Jie Jin Wang; Tien Y Wong; Monika A Czudowska; Albert Hofman; Andre G Uitterlinden; Roger C W Wolfs; Paulus T V M de Jong; Ben A Oostra; Andrew D Paterson; David A Mackey; Arthur A B Bergen; André Reis; Christopher J Hammond; Johannes R Vingerling; Hans G Lemij; Caroline C W Klaver; Cornelia M van Duijn
Journal:  PLoS Genet       Date:  2012-05-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.